Suppr超能文献

合成并评价含硼簇作为苯类似物的腺嘌呤衍生物作为 A、A、A 和 A 腺苷受体配体和选择性 A 激动剂。

Synthesis and evaluation of adenosine derivatives as A, A, A and A adenosine receptor ligands containing boron clusters as phenyl isosteres and selective A agonists.

机构信息

Laboratory of Medicinal Chemistry, Institute of Medical Biology PAS, Lodowa 106, 92-232, Łódź, Poland.

Laboratory of Biological Chemistry of Metal Ions, Institute of Biochemistry and Biophysics PAS, Pawińskiego 5a, 02-106, Warsaw, Poland.

出版信息

Eur J Med Chem. 2021 Nov 5;223:113607. doi: 10.1016/j.ejmech.2021.113607. Epub 2021 Jun 11.

Abstract

A series of adenosine and 2'-deoxyadenosine pairs modified with a 1,12-dicarba-closo-dodecaborane cluster or alternatively with a phenyl group at the same position was synthesized, and their affinity was determined at A, A, A and A adenosine receptors (ARs). While AR affinity differences were noted, a general tendency to preferentially bind A AR over other ARs was observed for most tested ligands. In particular, 5'-ethylcarbamoyl-N-(3-phenylpropyl)adenosine (18), N-(3-phenylpropyl)-2-chloroadenosine (24) and N-(3-phenylpropyl)adenosine (40) showed nanomolar A affinity (K 4.5, 6.4 and 7.5 nM, respectively). Among the boron cluster-containing compounds, the highest A affinity (K 206 nM) was for adenosine derivative 41 modified at C2. In the matched molecular pairs, analogs bearing boron clusters were found to show lower binding affinity for adenosine receptors than the corresponding phenyl analogs. Nevertheless, interestingly, several boron cluster modified adenosine ligands showed significantly higher A receptor selectivity than the corresponding phenyl analogs: 7vs. 8, 15vs. 16, 17vs. 18.

摘要

合成了一系列腺嘌呤和 2'-脱氧腺嘌呤对,在相同位置用 1,12-二碳杂-closo-十二硼烷簇或苯基修饰,并测定了它们在 A、A、A 和 A 腺苷受体(AR)上的亲和力。虽然注意到 AR 亲和力的差异,但观察到大多数测试配体优先与 A AR 结合而不是其他 AR。特别是,5'-乙基氨甲酰基-N-(3-苯基丙基)腺苷(18)、N-(3-苯基丙基)-2-氯腺苷(24)和 N-(3-苯基丙基)腺苷(40)表现出纳摩尔级的 A 亲和力(K 分别为 4.5、6.4 和 7.5 nM)。在含硼笼化合物中,C2 位修饰的腺嘌呤衍生物 41 具有最高的 A 亲和力(K 206 nM)。在匹配的分子对中,发现含有硼笼的类似物与相应的苯基类似物相比,对腺苷受体的结合亲和力较低。然而,有趣的是,几种硼笼修饰的腺苷配体显示出比相应的苯基类似物更高的 A 受体选择性:7 对 8、15 对 16、17 对 18。

相似文献

2
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
Purinergic Signal. 2015 Sep;11(3):389-407. doi: 10.1007/s11302-015-9460-9. Epub 2015 Jul 1.
7
N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
J Med Chem. 2007 Mar 22;50(6):1222-30. doi: 10.1021/jm060963u. Epub 2007 Feb 20.
8
Substituted 4-phenylthiazoles: Development of potent and selective A, A and dual A/A adenosine receptor antagonists.
Eur J Med Chem. 2020 Jan 15;186:111879. doi: 10.1016/j.ejmech.2019.111879. Epub 2019 Nov 15.

引用本文的文献

1
Development of Carborane-Based Benzothiazole Analogues as Cannabinoid Receptor Type 2 (CBR) Ligands.
ACS Omega. 2025 Aug 13;10(33):38264-38271. doi: 10.1021/acsomega.5c06508. eCollection 2025 Aug 26.
3
Advances in Diclofenac Derivatives: Exploring Carborane-Substituted N-Methyl and Nitrile Analogs for Anticancer Therapy.
ChemMedChem. 2025 Jun 2;20(11):e202500084. doi: 10.1002/cmdc.202500084. Epub 2025 Apr 14.
4
EGFR-Targeted Cellular Delivery of Therapeutic Nucleic Acids Mediated by Boron Clusters.
Int J Mol Sci. 2022 Nov 26;23(23):14793. doi: 10.3390/ijms232314793.
5
A Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity.
Pharmaceuticals (Basel). 2022 Jan 28;15(2):164. doi: 10.3390/ph15020164.

本文引用的文献

2
Comparative study of inorganic, boron-rich cluster and organic, phenyl adenosine modifications: synthesis and properties.
Future Med Chem. 2019 Jun;11(11):1267-1284. doi: 10.4155/fmc-2018-0517. Epub 2019 Jun 10.
3
Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y antagonists.
Vascul Pharmacol. 2019 Feb;113:47-56. doi: 10.1016/j.vph.2018.11.005. Epub 2018 Nov 22.
5
The therapeutic potential of purinergic signalling.
Biochem Pharmacol. 2018 May;151:157-165. doi: 10.1016/j.bcp.2017.07.016. Epub 2017 Jul 21.
6
In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification.
Bioorg Med Chem. 2016 Nov 1;24(21):5076-5087. doi: 10.1016/j.bmc.2016.08.028. Epub 2016 Aug 20.
7
Challenges and Opportunities for the Application of Boron Clusters in Drug Design.
J Med Chem. 2016 Sep 8;59(17):7738-58. doi: 10.1021/acs.jmedchem.5b01932. Epub 2016 May 10.
8
Recent developments with boron as a platform for novel drug design.
Expert Opin Drug Discov. 2016 Jun;11(6):569-78. doi: 10.1080/17460441.2016.1174687. Epub 2016 Apr 21.
10
Medicinal chemistry of adenosine, P2Y and P2X receptors.
Neuropharmacology. 2016 May;104:31-49. doi: 10.1016/j.neuropharm.2015.12.001. Epub 2015 Dec 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验